Two Dividend Stocks I Own and One I'm Looking to Buy
These stocks aren't going out of style.
Ventas Is Showing Some Softness Now, Raise Sell Stop Protection
The company is relying on several building blocks to return to growth.
6 REITs for an Aging Baby Boomer Population
Some companies are making an awful lot of money filling vital social and medical needs. Five investment experts give their stock picks for the rising demand for healthcare properties.
Evolus Stockholders May Be Frowning in the Short Run
Shares of the Botox competitor could correct/consolidate after a recent surge.
Centene Splits 2 For 1 Which Changes the Chart Levels but Not the Trends
With the stock split a fresh look at the split adjusted stock is now in order.
Alphabet's Healthcare Initiative Squares Off With Amazon, Apple
Healthcare is attracting some very healthy competition among mega-cap names.
Teladoc Gets a Positive Checkup So It's Time to Go Long
Teladoc looks like it is ready to move higher.
How to Play Johnson & Johnson Now That Earnings Are Out
There's a lot of runway left to adjust guidance numbers moving forward.
Two Sticking Points With Johnson & Johnson: Guidance and Litigation Expense
While the ongoing litigation could be seen as a deterrent to investment, I think the more interesting story is its upcoming AFib detection study with Apple.
Johnson & Johnson: How the Stock Looks on the Charts After Earnings
Experienced traders could approach the long side carefully.